Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 356,409 | 720,633 | 748,955 | 529,997 | 444,568 |
| Marketable Securities | 360,330 | 224,929 | 84,107 | 211,636 | 300,286 |
| Receivables | 773,079 | 93,003 | N/A | 112,500 | N/A |
| Other current assets | 0 | 0 | 0 | 112,500 | 0 |
| TOTAL | $1,562,821 | $1,066,337 | $862,295 | $993,114 | $772,365 |
| Non-Current Assets | |||||
| PPE Net | 42,834 | 26,610 | 20,251 | 17,291 | 17,946 |
| Investments And Advances | 201,388 | 0 | 50,680 | 0 | 0 |
| Intangibles | 50,224 | 50,358 | 50,491 | 50,624 | 50,757 |
| Other Non-Current Assets | 97,001 | 66,908 | 73,864 | 74,555 | 77,693 |
| TOTAL | $391,447 | $143,876 | $195,286 | $142,470 | $146,396 |
| Total Assets | $1,954,268 | $1,210,213 | $1,057,581 | $1,135,584 | $918,761 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,521 | 4,225 | 11,032 | 3,701 | 5,077 |
| Accrued Expenses | 236,512 | 64,845 | 64,074 | 70,069 | 76,936 |
| Other current liabilities | N/A | 68,500 | 26,200 | 24,400 | 10,600 |
| TOTAL | $341,242 | $233,724 | $146,024 | $361,099 | $99,064 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 98,209 | 96,154 | 44,718 | 262,929 | 6,451 |
| Other Non-Current Liabilities | 158,923 | 93,147 | 115,483 | 116,466 | 95,777 |
| TOTAL | $181,177 | $100,215 | $174,232 | $123,534 | $102,845 |
| Total Liabilities | $522,419 | $333,939 | $320,256 | $484,633 | $201,909 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 132,304 | 130,880 | 130,612 | 130,040 | 127,837 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -138,600 | -663,854 | -774,282 | -836,095 | -667,184 |
| Other shareholders' equity | -1,099 | -1,307 | -1,334 | -1,304 | -1,278 |
| TOTAL | $1,431,849 | $876,274 | $737,325 | $650,951 | $716,852 |
| Total Liabilities And Equity | $1,954,268 | $1,210,213 | $1,057,581 | $1,135,584 | $918,761 |